Ignite Creation Date:
2024-07-17 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06491563
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-28
Brief Title:
Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179 BRII-835 and PEG-IFNα Treating Chronic Hepatitis B Virus HBV Infection ENRICH
Sponsor:
Brii Biosciences Limited
Organization:
Brii Biosciences Limited
Study Overview
Official Title:
A Phase 2 Multicenter Open-label Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179 BRII-835 and Pegylated Interferon Alpha PEG-IFNα for the Treatment of Chronic Hepatitis B Virus HBV Infection ENRICH
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the efficacy and safety of the regimens containing BRII-179 BRII-835 and PEG-IFNα in adult participants with chronic hepatitis B virus HBV infection receiving nucleostide reverse transcriptase inhibitors NRTIs as background therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None